10-Year trends in the treatment and outcomes of patients with first-episode schizophrenia

Acta Psychiatrica Scandinavica

Volumn 122, Issue 5, 2010, Pages 356-366

  Nielsen, J ^a   Le Quach, P ^b   Emborg, C ^c   Foldager, L ^c,d   Correll, C U ^e,f  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e ZUCKER HILLSIDE HOSPITAL   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

antidepressants; antipsychotics; first episode; hospitalization; polypharmacy; schizophrenia

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BENZODIAZEPINE; CHLORPROMAZINE; CLOZAPINE; LITHIUM; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; ZIPRASIDONE;

ADULT; ARTICLE; DEPRESSION; DISEASE COURSE; HUMAN; LONG TERM CARE; PENSION; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; COHORT STUDIES; DENMARK; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LINEAR MODELS; MALE; POISSON DISTRIBUTION; SCHIZOPHRENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957348105     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2010.01576.x     Document Type: Article

References (43)

1. Bertelsen M, Jeppesen P, Petersen L et al. Course of illness in a sample of 265 patients with first-episode psychosis - five-year follow-up of the Danish OPUS trial. Schizophr Res 2009 107 : 173 178.
2. Goldberg TE, Burdick KE, Mccormack J et al. Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia. Schizophr Res 2009 107 : 262 266.
3. Tirupati NS, Rangaswamy T, Raman P. Duration of untreated psychosis and treatment outcome in schizophrenia patients untreated for many years. Aust N Z J Psychiatry 2004 38 : 339 343.
4. Larsen TK, Melle I, Auestad B et al. Early detection of first-episode psychosis: the effect on 1-year outcome. Schizophr Bull 2006 32 : 758 764.
5. Simonsen E, Friis S, Haahr U et al. Clinical epidemiologic first-episode psychosis: 1-year outcome and predictors. Acta Psychiatr Scand 2007 116 : 54 61.
6. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005 162 : 1785 1804.
7. Mcglashan TH. A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull 1988 14 : 515 542.
8. Robinson DG, Woerner MG, Alvir JM et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 1999 156 : 544 549.
9. Remington G, Kapur S, Zipursky RB. Pharmacotherapy of first-episode schizophrenia. Br J Psychiatry Suppl 1998 172 : 66 70.
10. Koster A, Lajer M, Lindhardt A, Rosenbaum B. Gender differences in first episode psychosis. Soc Psychiatry Psychiatr Epidemiol 2008 43 : 940 946.
11. Kahn RS, Fleischhacker WW, Boter H et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 2008 371 : 1085 1097.
12. Mcevoy JP, Lieberman JA, Perkins DO et al. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry 2007 164 : 1050 1060.
13. Kane JM. Schizophrenia. N Engl J Med 1996 334 : 34 41.
14. Munk-Jorgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull 1997 44 : 82 84.
15. Pedersen CB, Mortensen PB. Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry 2001 58 : 1039 1046.
16. Barr CE, Mednick SA, Munk-Jorgensen P. Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study. Arch Gen Psychiatry 1990 47 : 869 874.
17. Qin P, Nordentoft M. Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Arch Gen Psychiatry 2005 62 : 427 432.
18. Bock C, Bukh JD, Vinberg M, Gether U, Kessing LV. Validity of the diagnosis of a single depressive episode in a case register. Clin Pract Epidemol Ment Health 2009 5 : 4.
19. Allebeck P. The use of population based registers in psychiatric research. Acta Psychiatr Scand 2009 120 : 386 391.
20. World Health Organization. World Health Organization, collaborating centre Drug Statistics Methodology. Geneva : WHO, 2009.
21. Rijcken CA, Monster TB, Brouwers JR, De Jong-Van Den Berg LT. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses? J Clin Psychopharmacol 2003 23 : 657 659.
22. Atkins M, Burgess A, Bottomley C, Riccio M. Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Drug Inf Q 1997 21 : 224 226.
23. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003 64 : 663 667.
24. Yung AR, Mcgorry PD, Francey SM et al. PACE: a specialised service for young people at risk of psychotic disorders. Med J Aust 2007 187 : S43 S46.
25. Joa I, Johannessen JO, Auestad B et al. The key to reducing duration of untreated first psychosis: information campaigns. Schizophr Bull 2008 34 : 466 472.
26. Mcgorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996 22 : 305 326.
27. Larsen TK, Friis S, Haahr U et al. Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand 2001 103 : 323 334.
28. Barnes TR, Hutton SB, Chapman MJ, Mutsatsa S, Puri BK, Joyce EM. West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. Br J Psychiatry 2000 177 : 207 211.
29. Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychol Med 2004 34 : 277 284.
30. Verdoux H, Tournier M, Begaud B. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand 2010 121 : 4 10.
31. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009 373 : 31 41.
32. Weiden PJ. Antipsychotic-induced movement disorders - forgotten but not gone. Acta Psychiatr Scand 2008 117 : 401 402.
33. Verdoux H, Begaud B. Pharmaco-epidemiology: what do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions? Br J Psychiatry 2004 185 : 93 94.
34. Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull 2009 35 : 443 457.
35. Leucht S, Busch R, Kissling W, Kane JM. Early prediction of antipsychotic nonresponse among patients with schizophrenia. J Clin Psychiatry 2007 68 : 352 360.
36. Emsley R, Rabinowitz J, Medori R. Time course for antipsychotic treatment response in first-episode schizophrenia. Am J Psychiatry 2006 163 : 743 745.
37. Lehman AF, Lieberman JA, Dixon LB et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry 2004 161 : 1 56.
38. Williams CL, Johnstone BM, Kesterson JG, Javor KA, Schmetzer AD. Evaluation of antipsychotic and concomitant medication use patterns in patients with schizophrenia. Med Care 1999 37 : AS81 AS86.
39. Chakos MH, Glick ID, Miller AL et al. Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial. Psychiatr Serv 2006 57 : 1094 1101.
40. Whitehead C, Moss S, Cardno A, Lewis G. Antidepressants for the treatment of depression in people with schizophrenia: a systematic review. Psychol Med 2003 33 : 589 599.
41. Glick ID, Pham D, Davis JM. Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia. J Clin Psychiatry 2006 67 : 1261 1265.
42. Rummel C, Kissling W, Leucht S. Antidepressants as add-on treatment to antipsychotics for people with schizophrenia and pronounced negative symptoms: a systematic review of randomized trials. Schizophr Res 2005 80 : 85 97.
43. Siris SG, Bermanzohn PC, Mason SE, Shuwall MA. Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial. Arch Gen Psychiatry 1994 51 : 109 115.